Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)
קרן | National Cancer Institute/NIH |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 27/09/2019 |
פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
תיאור | This grant solicits applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic cancer research or clinical care. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.
Funding: $400,000 total Duration: 3 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due dates: 7.2.19, 28.4.19, 27.8.19 Full proposal due dates: 7.3.19, 28.5.19. 27.9.19
|
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 08/01/2019 |